95 related articles for article (PubMed ID: 4697687)
1. Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia.
Kwaan HC; Silverman S
Arch Dermatol; 1973 Apr; 107(4):571-3. PubMed ID: 4697687
[No Abstract] [Full Text] [Related]
2. [Reduced platelet aggregation in hereditary haemorrhagic telangiectasia].
Endo Y
Rinsho Byori; 1989 Apr; Spec No 81():46-53. PubMed ID: 2754811
[No Abstract] [Full Text] [Related]
3. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
Korzenik JR; Topazian MD; White R
N Engl J Med; 1994 Nov; 331(18):1236. PubMed ID: 7935675
[No Abstract] [Full Text] [Related]
4. Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia.
Sadick H; Bergler WF; Oulmi-Kagermann J; Naim R; Sadick M; Hörmann K; Riedel F
Arch Med Res; 2005; 36(5):468-73. PubMed ID: 16099323
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic bleeding complicated by factor 13 defect.
Baggett RT; Hampton JW; Bird RM
Arch Intern Med; 1968 Jun; 121(6):539-44. PubMed ID: 5652406
[No Abstract] [Full Text] [Related]
6. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid.
Kok P; Astrup T
Thromb Diath Haemorrh; 1972 Feb; 27(1):77-87. PubMed ID: 4260740
[No Abstract] [Full Text] [Related]
7. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
Pechet L; Groth CG; Daloze PM
J Lab Clin Med; 1969 Jan; 73(1):91-102. PubMed ID: 4883102
[No Abstract] [Full Text] [Related]
8. [Fibrinolytic late hemorrhage following prostatectomy. Successful management using Cohn's fraction in combination with epsilon-aminocaproic acid].
Sauerland D
Zentralbl Chir; 1968 Apr; 93(15):546-9. PubMed ID: 5662433
[No Abstract] [Full Text] [Related]
9. [Fibrinolytic activity in cutaneous lesions of hereditary hemorrhagic telangiectasia].
Watanabe M; Hanawa S; Morishima T
Nihon Hifuka Gakkai Zasshi; 1985 Jan; 95(1):11-6. PubMed ID: 4039768
[No Abstract] [Full Text] [Related]
10. [Hemostasis in hereditary hemorrhagic telangiectasia (author's transl)].
Muntean W; Kaspar G; Stöffler G; Petek W
Padiatr Padol; 1978; 13(2):205-10. PubMed ID: 643297
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic significance of the blood coagulation factor 3 in hemorrhagic diathesis].
Chistiakova VG
Sov Med; 1969 Nov; 32(11):135-7. PubMed ID: 5382880
[No Abstract] [Full Text] [Related]
12. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemorrhagic telangiectasia: analysis of platelet aggregation and fibrinolytic system in seven patients.
Sureda A; César J; García Frade LJ; García Avello A; Fernández Fuertes I; Navarro JL
Acta Haematol; 1991; 85(3):119-23. PubMed ID: 1710408
[TBL] [Abstract][Full Text] [Related]
14. Trasylol therapy of haemorrhage in surgical patients.
Amris CJ
Acta Chir Scand Suppl; 1967; 378():45-52. PubMed ID: 5300106
[No Abstract] [Full Text] [Related]
15. [Assessment of haemostatic factors in Rendu-Osler disease (author's transl)].
Martínez Canaveri A; González de Mondini N; Lazzari MA
Sangre (Barc); 1979; 24(5):553-8. PubMed ID: 538550
[No Abstract] [Full Text] [Related]
16. [Changes in the blood coagulation system in Osler-Rendu disease (hereditary hemorrhagic telangiectasia)].
Tepliuk TB; Samarskaia GS; Fedulova GA; Soboleva SS; Tokarev IuN
Gematol Transfuziol; 1985 Oct; 30(10):23-6. PubMed ID: 4065521
[No Abstract] [Full Text] [Related]
17. Hemostatic effects of tamoxifen in hereditary hemorrhagic telangiectasia.
Zacharski LR; Dunbar SD; Newsom WA
Thromb Haemost; 2001 Feb; 85(2):371-2. PubMed ID: 11246565
[No Abstract] [Full Text] [Related]
18. "Studies on the levels of fibrinolytic-activity with special reference to its range of activity on various substrates (including coagulation factors) in healthy controls". I.
Bharadwaj TP; Sen NK
J Assoc Physicians India; 1971 Jan; 19(1):43-8. PubMed ID: 5560025
[No Abstract] [Full Text] [Related]
19. [Influence of fibrinolytic activation on the determination of factor XIII].
Pola P; Bianco S; Bizzi B
Policlinico Prat; 1969 Feb; 76(8):233-6. PubMed ID: 5778893
[No Abstract] [Full Text] [Related]
20. The coagulation disorder in promyelocytic leukemia.
Straub PW; Frick PG
Helv Med Acta; 1967 Dec; 34(1):44-53. PubMed ID: 5242897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
